Sevelamer Carbonate
These highlights do not include all the information needed to use SEVELAMER CARBONATE safely and effectively. See full prescribing information for SEVELAMER CARBONATE. SEVELAMER CARBONATE tablets, for oral use SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000
3abc32fe-1bfc-4759-8f7c-36095e221b06
HUMAN PRESCRIPTION DRUG LABEL
Dec 7, 2023
Winthrop U.S, a business of sanofi-aventis U.S. LLC
DUNS: 824676584
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sevelamer Carbonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Sevelamer Carbonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
Sevelamer Carbonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
Sevelamer Carbonate
Product Details
FDA regulatory identification and product classification information